(firstQuint)Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH.

 This study is designed as a pivotal study to compare the safety and efficacy of a selected dose regimen of somavaratan to daily rhGH.

 The study is a randomized, multi-center, open label study of 12 months duration.

 The primary endpoint is height velocity at 12 months.

.

 Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH@highlight

The trial will compare a twice-monthly somavaratan dosing regimen for non-inferiority of treatment effect against daily injections of rhGH.

